#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14784	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2489	731.7	0	.	n	.	0	C1450T	SNP	1450	1450	C	1865	1865	T	970	T,G,C,A	962,6,1,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14784	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2489	731.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1599	1599	C	975	C	975	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24340	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4002	757.9	0	.	n	.	0	G1337A	SNP	1337	1337	G	1951	1951	A	1012	A,G	1011,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24340	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4002	757.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2585	2585	C	828	C,T,G	825,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24340	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4002	757.9	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3211	3211	T	859	T	859	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24340	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4002	757.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2659	2659	A	769	A	769	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1660	folP	852	852	93.78	folP.l15.c4.ctg.1	2057	100.7	0	.	p	.	0	G5V	NONSYN	13	15	GGT	586	588	GTT	120;120;120	G,C;T;T	119,1;120;120	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1660	folP	852	852	93.78	folP.l15.c4.ctg.1	2057	100.7	0	.	p	.	0	E12K	NONSYN	34	36	GAA	607	609	AAA	135;136;137	A;A;A,T	135;136;136,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1660	folP	852	852	93.78	folP.l15.c4.ctg.1	2057	100.7	0	.	p	.	0	F31L	NONSYN	91	93	TTT	664	666	TTG	187;189;187	T;T;G	187;189;187	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1660	folP	852	852	93.78	folP.l15.c4.ctg.1	2057	100.7	0	.	p	.	0	K42Q	NONSYN	124	126	AAA	697	699	CAA	211;213;212	C;A;A,G	211;213;211,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1660	folP	852	852	93.78	folP.l15.c4.ctg.1	2057	100.7	0	.	p	.	0	S75P	NONSYN	223	225	TCC	796	798	CCT	186;186;180	C,G;C;T,G,C	185,1;186;178,1,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1660	folP	852	852	93.78	folP.l15.c4.ctg.1	2057	100.7	0	.	p	.	0	V87A	NONSYN	259	261	GTA	832	834	GCA	153;152;151	G;C;A	153;152;151	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1660	folP	852	852	93.78	folP.l15.c4.ctg.1	2057	100.7	0	.	p	.	0	V130L	NONSYN	388	390	GTC	961	963	CTC	192;193;195	C;T,G,A;C	192;190,2,1;195	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1660	folP	852	852	93.78	folP.l15.c4.ctg.1	2057	100.7	0	.	p	.	0	R135C	NONSYN	403	405	CGC	976	978	TGT	199;198;199	T;G;T,G,C	199;198;197,1,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1660	folP	852	852	93.78	folP.l15.c4.ctg.1	2057	100.7	0	.	p	.	0	T137A	NONSYN	409	411	ACG	982	984	GCG	205;206;206	G,T,A;C;G	203,1,1;206;206	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1660	folP	852	852	93.78	folP.l15.c4.ctg.1	2057	100.7	0	.	p	.	0	E151K	NONSYN	451	453	GAA	1024	1026	AAG	217;218;220	A;A;G,A	217;218;219,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1660	folP	852	852	93.78	folP.l15.c4.ctg.1	2057	100.7	0	.	p	.	0	T152N	NONSYN	454	456	ACC	1027	1029	AAT	220;222;223	A;A;T	220;222;223	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1660	folP	852	852	93.78	folP.l15.c4.ctg.1	2057	100.7	0	.	p	.	0	F218L	NONSYN	652	654	TTT	1225	1227	TTG	143;142;140	T;T;G,T	143;142;139,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1660	folP	852	852	93.78	folP.l15.c4.ctg.1	2057	100.7	1	SNP	p	R228S	1	R228S	NONSYN	682	684	CGT	1255	1257	AGC	132;133;134	A;G;C	132;133;134	folP.Neisseria_meningitidis_M01_240149_v1_00504:1:1:R228S:folP.228S:Resistance to sulphonamides	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1660	folP	852	852	93.78	folP.l15.c4.ctg.1	2057	100.7	0	.	p	.	0	V251L	NONSYN	751	753	GTG	1324	1326	CTG	119;120;119	C;T;G	119;120;119	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1660	folP	852	852	93.78	folP.l15.c4.ctg.1	2057	100.7	0	.	p	.	0	A253S	NONSYN	757	759	GCT	1330	1332	TCC	118;118;118	T;C;C	118;118;118	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1660	folP	852	852	93.78	folP.l15.c4.ctg.1	2057	100.7	0	.	p	.	0	A258V	NONSYN	772	774	GCG	1345	1347	GTG	131;134;135	G;T;G	131;134;135	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1660	folP	852	852	93.78	folP.l15.c4.ctg.1	2057	100.7	0	.	p	.	0	V275A	NONSYN	823	825	GTG	1396	1398	GCG	177;178;177	G;C;G	177;178;177	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5490	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3733	183.3	1	SNP	p	S91F	0	.	.	271	273	TCC	733	735	TCC	197;198;196	T;C,A;C	197;197,1;196	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5490	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3733	183.3	1	SNP	p	D95N	0	.	.	283	285	GAC	745	747	GAC	207;206;206	G,T;A,T;C	206,1;205,1;206	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5490	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3733	183.3	1	SNP	p	D95G	0	.	.	283	285	GAC	745	747	GAC	207;206;206	G,T;A,T;C	206,1;205,1;206	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_L_00489c	mtrR.WHO_L_00489c	1	1	531	1818	mtrR	633	633	99.68	mtrR.l15.c4.ctg.1	1740	130.4	0	.	p	.	0	Q133trunc	TRUNC	397	397	C	976	976	T	209	T	209	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1124	mtrR_promoter	250	250	100.0	mtrR_promoter.l6.c30.ctg.1	1397	100.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4650	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3390	170.9	0	.	p	.	0	V384I	NONSYN	1150	1152	GTC	1699	1701	ATC	242;239;238	A,G;T;C	241,1;239;238	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4650	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3390	170.9	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1852	1854	GCA	230;229;230	G;C,T;A,G	230;227,2;228,2	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4650	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3390	170.9	1	SNP	p	D86N	0	.	.	256	258	GAC	805	807	GAC	208;206;203	G;A;C	208;206;203	parC.WHO_G_00206c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4650	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3390	170.9	1	SNP	p	S87R	0	.	.	259	261	AGT	808	810	AGT	203;203;205	A;G;T	203;203;205	parC.WHO_G_00206c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4650	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3390	170.9	1	SNP	p	S87I	0	.	.	259	261	AGT	808	810	AGT	203;203;205	A;G;T	203;203;205	parC.WHO_G_00206c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4650	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3390	170.9	1	SNP	p	S87W	0	.	.	259	261	AGT	808	810	AGT	203;203;205	A;G;T	203;203;205	parC.WHO_G_00206c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4650	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3390	170.9	1	SNP	p	S88P	0	.	.	262	264	TCC	811	813	TCC	205;206;208	T;C,G;C,T	205;205,1;207,1	parC.WHO_G_00206c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4328	parE	1986	1986	99.95	parE.l15.c4.ctg.1	3073	175.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1804	1806	GGC	232;229;228	G,T,C;G;C	229,2,1;229;228	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.14.001	penA.14.001	1	1	27	4280	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2861	186.7	1	SNP	p	A311V	0	.	.	931	933	GCA	1465	1467	GCA	268;267;272	G;C;A	268;267;272	penA.14.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4280	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2861	186.7	1	SNP	p	I312M	0	.	.	934	936	ATC	1468	1470	ATC	275;276;277	A;T;C,G	275;276;276,1	penA.14.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4280	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2861	186.7	1	SNP	p	V316P	0	.	.	946	948	GTG	1480	1482	GTG	266;263;263	G,A;T,G;G,T	265,1;261,2;262,1	penA.14.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4280	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2861	186.7	1	SNP	p	V316T	0	.	.	946	948	GTG	1480	1482	GTG	266;263;263	G,A;T,G;G,T	265,1;261,2;262,1	penA.14.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4280	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2861	186.7	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1984	1986	ACC	262;261;261	A,G;C,T;C,T	261,1;259,2;259,2	penA.14.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4280	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2861	186.7	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2038	2040	GCG	245;245;244	G;C;G,T,A	245;245;241,2,1	penA.14.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4280	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2861	186.7	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2038	2040	GCG	245;245;244	G;C;G,T,A	245;245;241,2,1	penA.14.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4280	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2861	186.7	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2161	2163	GGT	232;230;228	G,A;G,C;T,C	231,1;229,1;227,1	penA.14.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4280	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2861	186.7	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2170	2172	GGC	231;234;236	G;G;C	231;234;236	penA.14.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4280	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2861	186.7	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2188	2190	CCG	236;238;234	C,A;C,G;G	235,1;237,1;234	penA.14.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5572	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3657	190.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2472	porA	1146	1146	99.74	porA.l15.c30.ctg.1	2304	134.0	0	.	p	.	0	S22G	NONSYN	64	66	AGC	577	579	GGC	181;180;180	G,A,C;G;C	178,2,1;180;180	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2472	porA	1146	1146	99.74	porA.l15.c30.ctg.1	2304	134.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	759	759	C	189	C,A	188,1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	268	porB1a	984	222	90.09	porB1a.l6.c30.ctg.1	376	30.6	0	.	p	.	0	V258L	NONSYN	772	774	GTA	12	14	TTA	28;29;32	T;T;A	28;29;32	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	268	porB1a	984	222	90.09	porB1a.l6.c30.ctg.1	376	30.6	0	.	p	.	0	S271T	NONSYN	811	813	TCG	51	53	ACT	60;60;60	A;C;T	60;60;60	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	268	porB1a	984	222	90.09	porB1a.l6.c30.ctg.1	376	30.6	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	57	59	CAT	60;60;60	C;A;T	60;60;60	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	268	porB1a	984	222	90.09	porB1a.l6.c30.ctg.1	376	30.6	0	.	p	.	0	D274S	NONSYN	820	822	GAT	60	62	AGT	60;60;60	A;G;T	60;60;60	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	268	porB1a	984	222	90.09	porB1a.l6.c30.ctg.1	376	30.6	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	69	71	TAC	60;60;60	T;A;C	60;60;60	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	268	porB1a	984	222	90.09	porB1a.l6.c30.ctg.1	376	30.6	0	.	p	.	0	R307A	NONSYN	919	921	AGA	159	161	GCA	2;2;2	G;C;A	2;2;2	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	268	porB1a	984	222	90.09	porB1a.l6.c30.ctg.1	376	30.6	0	.	p	.	0	T311A	NONSYN	931	933	ACA	171	173	GCA	2;2;2	G;C;A	2;2;2	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	268	porB1a	984	222	90.09	porB1a.l6.c30.ctg.1	376	30.6	0	.	p	.	0	E312D	NONSYN	934	936	GAA	174	176	GAC	2;2;2	G;A;C	2;2;2	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	268	porB1a	984	222	90.09	porB1a.l6.c30.ctg.1	376	30.6	0	.	p	.	0	F314I	NONSYN	940	942	TTC	180	182	ATC	2;2;2	A;T;C	2;2;2	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	268	porB1a	984	222	90.09	porB1a.l6.c30.ctg.1	376	30.6	0	.	p	.	0	A316S	NONSYN	946	948	GCG	186	188	TCG	2;2;2	T;C;G	2;2;2	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	268	porB1a	984	222	90.09	porB1a.l6.c30.ctg.1	376	30.6	0	.	p	.	0	V318A	NONSYN	952	954	GTC	192	194	GCC	2;2;2	G;C;C	2;2;2	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	268	porB1a	984	222	90.09	porB1a.l6.c30.ctg.1	376	30.6	0	.	p	.	0	G319S	NONSYN	955	957	GGC	195	197	AGC	2;2;2	A;G;C	2;2;2	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	268	porB1a	984	222	90.09	porB1a.l6.c30.ctg.1	376	30.6	0	.	p	.	0	G320A	NONSYN	958	960	GGT	198	200	GCC	2;2;2	G;C;C	2;2;2	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	268	porB1a	984	222	90.09	porB1a.l6.c30.ctg.1	376	30.6	0	.	p	.	0	G322V	NONSYN	964	966	GGT	204	206	GTT	2;1;1	G;T;T	2;1;1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2902	porB1b	1047	1047	99.14	porB1b.l6.c17.ctg.1	1728	207.2	0	.	p	.	0	N38E	NONSYN	112	114	AAT	506	508	GAA	262;262;261	G;A;A	262;262;261	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2902	porB1b	1047	1047	99.14	porB1b.l6.c17.ctg.1	1728	207.2	0	.	p	.	0	N134D	NONSYN	400	402	AAT	794	796	GAT	247;246;244	G;A;T	247;246;244	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2902	porB1b	1047	1047	99.14	porB1b.l6.c17.ctg.1	1728	207.2	0	.	p	.	0	P175S	NONSYN	523	525	CCA	917	919	TCA	240;239;234	T;C,A;A	240;237,2;234	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2902	porB1b	1047	1047	99.14	porB1b.l6.c17.ctg.1	1728	207.2	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1046	1048	GTC	260;261;258	G,T;T;C,G,A	258,2;261;256,1,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2902	porB1b	1047	1047	99.14	porB1b.l6.c17.ctg.1	1728	207.2	0	.	p	.	0	R258H	NONSYN	772	774	CGT	1166	1168	CAT	288;289;289	C,A,G;A,C;T	286,1,1;288,1;289	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2902	porB1b	1047	1047	99.14	porB1b.l6.c17.ctg.1	1728	207.2	0	.	p	.	0	S292T	NONSYN	874	876	TCT	1268	1270	ACT	223;222;222	A,C;C;T	222,1;222;222	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2902	porB1b	1047	1047	99.14	porB1b.l6.c17.ctg.1	1728	207.2	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1376	1378	GCA	235;235;237	G;C;A,T	235;235;236,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2902	porB1b	1047	1047	99.14	porB1b.l6.c17.ctg.1	1728	207.2	1	SNP	p	G120K	1	.	.	358	360	AAG	752	754	AAG	239;240;240	A;A,G;G,T	239;239,1;239,1	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2902	porB1b	1047	1047	99.14	porB1b.l6.c17.ctg.1	1728	207.2	1	SNP	p	A121D	1	.	.	361	363	GAC	755	757	GAC	238;238;237	G;A;C	238;238;237	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2902	porB1b	1047	1047	99.14	porB1b.l6.c17.ctg.1	1728	207.2	1	SNP	p	D121N	0	.	.	361	363	GAC	755	757	GAC	238;238;237	G;A;C	238;238;237	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	10156	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5276	240.1	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2196	2198	CAT	264;266;265	C,A;A;T,G	263,1;266;264,1	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1434	rpsJ	312	312	100.0	rpsJ.l6.c30.ctg.1	1467	121.7	1	SNP	p	V57M	1	.	.	169	171	ATG	679	681	ATG	239;240;243	A;T,G;G	239;239,1;243	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
